Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage

por Kelley, Mark R., Fehrenbacher, Jill C.
Publicado 2017

Oxidative DNA Damage: A Role in Altering Neuronal Function

por Behrouzi, Adib, Kelley, Mark R., Fehrenbacher, Jill C.
Publicado 2022

Long-term exposure to PGE(2) causes homologous desensitization of receptor-mediated activation of protein kinase A

por Malty, Ramy Habashy, Hudmon, Andy, Fehrenbacher, Jill C., Vasko, Michael R.
Publicado 2016

Oxidative DNA Damage and Cisplatin Neurotoxicity Is Exacerbated by Inhibition of OGG1 Glycosylase Activity and APE1 Endonuclease Activity in Sensory Neurons

por Behrouzi, Adib, Xia, Hanyu, Thompson, Eric L., Kelley, Mark R., Fehrenbacher, Jill C.
Publicado 2022

APE1/Ref-1 – One Target with Multiple Indications: Emerging Aspects and New Directions

por Mijit, Mahmut, Caston, Rachel, Gampala, Silpa, Fishel, Melissa L., Fehrenbacher, Jill, Kelley, Mark R.
Publicado 2021

Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic

por Shah, Fenil, Logsdon, Derek, Messmann, Richard A., Fehrenbacher, Jill C., Fishel, Melissa L., Kelley, Mark R.
Publicado 2017

The impact of SBF2 on taxane-induced peripheral neuropathy

por Cunningham, Geneva M., Shen, Fei, Wu, Xi, Cantor, Erica L., Gardner, Laura, Philips, Santosh, Jiang, Guanglong, Bales, Casey L., Tan, Zhiyong, Liu, Yunlong, Wan, Jun, Fehrenbacher, Jill C., Schneider, Bryan P.
Publicado 2022